Global Vaccine Excipients Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Vaccine Excipients Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The manufacture and composition of vaccines are complex and are strictly regulated to maximize potency and safety. In addition to antigens, vaccines also contain some important substances—vaccine excipients. Vaccine excipients comprise all chemical compounds used in the production of vaccines, such as vaccine stabilizers, vaccine emulsifiers, preservatives and vaccine adjuvants.
Vaccine Excipients report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vaccine Excipients market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Research Applications and Commercial Applications are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vaccine Excipients industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Vaccine Excipients key manufacturers include Curia, Croda Pharma, Alfa Chemistry, A & C, Avantor, GS, SEPPIC, Novavax and Dynavax Technologies, etc. Curia, Croda Pharma, Alfa Chemistry are top 3 players and held % sales share in total in 2022.
Vaccine Excipients can be divided into Vaccine Stabilizers, Vaccine Emulsifiers, Vaccine Adjuvants and Preservatives, etc. Vaccine Stabilizers is the mainstream product in the market, accounting for % sales share globally in 2022.
Vaccine Excipients is widely used in various fields, such as Research Applications and Commercial Applications, etc. Research Applications provides greatest supports to the Vaccine Excipients industry development. In 2022, global % sales of Vaccine Excipients went into Research Applications filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vaccine Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Curia
Croda Pharma
Alfa Chemistry
A & C
Avantor
GS
SEPPIC
Novavax
Dynavax Technologies
Sanofi
Zhifei Biological
Escon
Rico Bio
CSL Limited
Creative Biolabs
Central Drug House
Segment by Type
Vaccine Stabilizers
Vaccine Emulsifiers
Vaccine Adjuvants
Preservatives
Research Applications
Commercial Applications
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vaccine Excipients market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vaccine Excipients, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vaccine Excipients industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Vaccine Excipients in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vaccine Excipients introduction, etc. Vaccine Excipients Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Vaccine Excipients market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Vaccine Excipients report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vaccine Excipients market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Research Applications and Commercial Applications are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vaccine Excipients industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Vaccine Excipients key manufacturers include Curia, Croda Pharma, Alfa Chemistry, A & C, Avantor, GS, SEPPIC, Novavax and Dynavax Technologies, etc. Curia, Croda Pharma, Alfa Chemistry are top 3 players and held % sales share in total in 2022.
Vaccine Excipients can be divided into Vaccine Stabilizers, Vaccine Emulsifiers, Vaccine Adjuvants and Preservatives, etc. Vaccine Stabilizers is the mainstream product in the market, accounting for % sales share globally in 2022.
Vaccine Excipients is widely used in various fields, such as Research Applications and Commercial Applications, etc. Research Applications provides greatest supports to the Vaccine Excipients industry development. In 2022, global % sales of Vaccine Excipients went into Research Applications filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vaccine Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Curia
Croda Pharma
Alfa Chemistry
A & C
Avantor
GS
SEPPIC
Novavax
Dynavax Technologies
Sanofi
Zhifei Biological
Escon
Rico Bio
CSL Limited
Creative Biolabs
Central Drug House
Segment by Type
Vaccine Stabilizers
Vaccine Emulsifiers
Vaccine Adjuvants
Preservatives
Segment by Application
Research Applications
Commercial Applications
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vaccine Excipients market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vaccine Excipients, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vaccine Excipients industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Vaccine Excipients in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vaccine Excipients introduction, etc. Vaccine Excipients Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Vaccine Excipients market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
